Current Treatment Options in Neurology
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 1.3 | Q4 | 19.3% | 0.475 | Q3 | 59.1% |
| 2024 | 1.8 | Q3 | 32.3% | 0.721 | Q2 | 74.5% |
| 2023 | 1.8 | Q3 | 42.6% | 0.591 | Q3 | 70.5% |
| 2022 | 2.0 | Q4 | 40.8% | 0.696 | Q2 | 76.7% |
| 2021 | 4.0 | Q2 | 75.0% | 0.861 | Q2 | 83.1% |
| 2020 | — | — | 1.078 | Q2 | 86.9% | |
| 2019 | — | — | 1.034 | Q2 | 86.4% | |
| 2018 | — | — | 1.199 | Q1 | 87.9% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1534-3138
ISSN
1092-8480
country
UScoverage
1999-2026